By the numbers: How Express Scripts saved members money in 2022
An analysis of 2022 Express Scripts data has found that members are paying less at the pharmacy counter.
Read More
Research challenges PBM rebate narrative on rising insulin prices
Data shows that the greatest rates of price increase happened when rebates were at their lowest.
Read More
Designing plans to manage comorbid conditions
Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.
Read More
Addressing obesity in the workplace
As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.
Read More
Cardiodiabesity 101
More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...
Read More
A plan sponsor’s guide to GLP-1 medications for weight loss
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Read More